These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20699109)

  • 21. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
    Xiang XS; Li N; Zhao YZ; Li QR; Li JS
    Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of soluble human thymosin alpha 1 in Escherichia coli.
    Chen PF; Zhang HY; Fu GF; Xu GX; Hou YY
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):147-51. PubMed ID: 15685373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymosin alpha1 is a time and dose-dependent antagonist of dexamethasone-induced apoptosis of murine thymocytes in vitro.
    Baumann CA; Badamchian M; Goldstein AL
    Int J Immunopharmacol; 2000 Dec; 22(12):1057-66. PubMed ID: 11137612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
    Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN
    J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.
    Romani L; Bistoni F; Perruccio K; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Bistoni G; Rasi G; Velardi A; Fallarino F; Garaci E; Puccetti P
    Blood; 2006 Oct; 108(7):2265-74. PubMed ID: 16741252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.
    Xu YG; Guan XT; Liu ZM; Tian CY; Cui LC
    Appl Environ Microbiol; 2015 Jun; 81(11):3745-52. PubMed ID: 25819954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymosin alpha 1: from bench to bedside.
    Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G
    Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin α1 and cancer: action on immune effector and tumor target cells.
    Garaci E; Pica F; Serafino A; Balestrieri E; Matteucci C; Moroni G; Sorrentino R; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P
    Ann N Y Acad Sci; 2012 Oct; 1269():26-33. PubMed ID: 23045967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fusion expression of human thymosin alpha 1 in Escherichia coli].
    Xiu ZY; Yu Y; Chen CQ
    Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):541-5. PubMed ID: 12561195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.
    Mandaliti W; Nepravishta R; Pica F; Vallebona PS; Garaci E; Paci M
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
    Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
    Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
    Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
    Mao L
    Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.
    Panatto D; Amicizia D; Lai PL; Camerini R; De Rosa A; Gasparini R
    J Prev Med Hyg; 2011 Sep; 52(3):111-5. PubMed ID: 22010537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
    Liaw YF
    J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S73-5. PubMed ID: 15546254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
    Liu F; Wang HM; Wang T; Zhang YM; Zhu X
    BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
    Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
    Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.
    Fan YZ; Chang H; Yu Y; Liu J; Wang R
    Peptides; 2006 Sep; 27(9):2165-73. PubMed ID: 16644063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.